Literature DB >> 9657589

Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. European Respiratory Society.

P De Vuyst1, A Karjalainen, P Dumortier, J C Pairon, E Monsó, P Brochard, H Teschler, A Tossavainen, A Gibbs.   

Abstract

Microscopic techniques for analysing asbestos fibres in lung tissue and bronchoalveolar lavage have provided major information in the understanding of asbestos-related diseases. These analyses are increasingly applied for clinical work and medicolegal problems. Differences in sampling, preparation and counting techniques, definitions of reference populations and expression of results have caused major difficulties in comparing results from different laboratories. Therefore it appeared necessary to set a goal to harmonize these analyses between the European laboratories active in this field. This article summarizes the work of a European Respiratory Society working group with participation from nine European laboratories. The five main issues touched upon are: 1) definitions of control populations and reference levels; 2) sampling, preparation and analytical techniques; 3) asbestos fibres in lung tissues in different pathologies; 4) asbestos bodies in lung tissue, bronchoalveolar lavage and sputum; and 5) basis for the interpretation of fibres and asbestos bodies in biological samples. These guidelines indicate the crucial importance of several factors for the interpretation of the results; namely, adequate sampling, comparable analytical procedures and expression of the results, the use of well-defined reference populations, and a comprehensive understanding of the factors affecting the fibre retention and the dose-responses associated with the different asbestos-related diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657589     DOI: 10.1183/09031936.98.11061416

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

1.  [Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma].

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Pe'choux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-10

2.  First Identification of Pulmonary Asbestos Fibres in a Spanish Population.

Authors:  M I Velasco-García; M J Cruz; C Diego; M A Montero; D Álvarez-Simón; J Ferrer
Journal:  Lung       Date:  2017-08-08       Impact factor: 2.584

3.  Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzköy, Cappadocia, Turkey.

Authors:  P Dumortier; L Coplü; I Broucke; S Emri; T Selcuk; V de Maertelaer; P De Vuyst; I Baris
Journal:  Occup Environ Med       Date:  2001-04       Impact factor: 4.402

Review 4.  [The German Mesothelioma Register : Current pathological diagnostics and services].

Authors:  I S Feder; M Jülich; A Tannapfel; I Tischoff
Journal:  Pathologe       Date:  2018-12       Impact factor: 1.011

5.  Bronchoalveolar neutrophilia inversely correlates with DLCO at diagnosis in asbestosis but not lung function decline at 1 year.

Authors:  Gareth Walters; Sushil Agarwal; Karanvir Singh; P Sherwood Burge; Emmet E McGrath
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

6.  Asbestos danger in central Europe is not yet over - the situation in the Czech Republic.

Authors:  Miroslav Urban; Daniela Pelclová; Pavel Urban; Michael Vít; Peter Urban; Zdenka Fenclová
Journal:  Cent Eur J Public Health       Date:  2022-06       Impact factor: 1.154

7.  Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome.

Authors:  Brock C Christensen; E A Houseman; John J Godleski; Carmen J Marsit; Jennifer L Longacker; Cora R Roelofs; Margaret R Karagas; Margaret R Wrensch; Ru-Fang Yeh; Heather H Nelson; Joe L Wiemels; Shichun Zheng; John K Wiencke; Raphael Bueno; David J Sugarbaker; Karl T Kelsey
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

8.  Asbestos bodies count and morphometry in bulk lung tissue samples by non-invasive X-ray micro-tomography.

Authors:  Fabrizio Bardelli; Francesco Brun; Silvana Capella; Donata Bellis; Claudia Cippitelli; Alessia Cedola; Elena Belluso
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

Review 9.  Non-neoplastic and neoplastic pleural endpoints following fiber exposure.

Authors:  V Courtney Broaddus; Jeffrey I Everitt; Brad Black; Agnes B Kane
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

Review 10.  Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma.

Authors:  B W Case; J L Abraham; G Meeker; F D Pooley; K E Pinkerton
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.